These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5358782)

  • 1. [Sclerodermic pneumofibrosis (clinical-functional characteristics)].
    Guseva NG; Falomeeva OM; Sysoev VF; Mach ES
    Ter Arkh; 1969 Mar; 41(3):36-41. PubMed ID: 5358782
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interstitial pulmonary fibrosis in the pathogenesis of pulmonary heart disease].
    Stanĕk V; Widimský J; Kasalický J
    Vnitr Lek; 1969 Jun; 15(6):546-56. PubMed ID: 5790732
    [No Abstract]   [Full Text] [Related]  

  • 3. [An anatomo-clinical case of diffuse pulmonary fibrosis with chronic sclerodermic pulmonary heart].
    Plauchu M; Brune J; Rousset H; Loire R; Galy P
    Lyon Med; 1970 Dec; 224(41):817-23. PubMed ID: 5485438
    [No Abstract]   [Full Text] [Related]  

  • 4. [The cardio-circulatory system in scleroderma: radiological aspects of sclerodermic cardio-angiopathy].
    Alé G; Pompili G
    Nunt Radiol; 1968 Nov; 34(11):1251-68. PubMed ID: 4245375
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinicofunctional aspects of the pulmonary complications of scleroderma].
    Rancea D; Nicoară O; Coman N
    Ftiziologia; 1973; 22(1):45-8. PubMed ID: 4690195
    [No Abstract]   [Full Text] [Related]  

  • 6. [Frequency of electrocardiographic signs of chronic cor pulmonale in asbestosis].
    Tomasini M; Sartorelli E
    Med Lav; 1971 Dec; 62(12):549-53. PubMed ID: 4261348
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sclerodermal cardiopathy. Apropos of 155 cases of generalised scleroderma].
    Juillet Y; Bogaert O; Crickx B; Fiessinger JN; Housset E
    Arch Mal Coeur Vaiss; 1980 Sep; 73(9):1019-26. PubMed ID: 6776923
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pulmonary lesions in connective tissue diseases, with special reference to progressive systemic sclerosis].
    Yutani C; Kim S; Miyaji T; Uematsu K
    Nihon Rinsho; 1975 Nov; 33(11):3333-7. PubMed ID: 1239563
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary complications: one of the most challenging complications of systemic sclerosis.
    Wells AU; Steen V; Valentini G
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii40-4. PubMed ID: 19487223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffuse pulmonary fibrosis in histiocytosis X in adults].
    Turiaf J; Jeanjean Y; Basset F; Hugues FC
    Poumon Coeur; 1973; 29(5):625-30. PubMed ID: 4793542
    [No Abstract]   [Full Text] [Related]  

  • 11. [A study of pulmonary function of idiopathic interstitial pneumonia--pulmonary diffusing capacity and small airway dynamics].
    Saito G
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Sep; 22(9):742-50. PubMed ID: 6521087
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary fibrosis in scleroderma and dermatomyositis.
    Brundin A
    Scand J Respir Dis; 1970; 51(3):160-70. PubMed ID: 5508404
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmonary disease in sclerodermia. Radiologic and functional study (65 cases)].
    Brune J; Moulin G; Wiesendanger T; Brune A; Arnaud A; Dorsit G; Galy P
    J Fr Med Chir Thorac; 1970 Apr; 24(3):299-311. PubMed ID: 5421065
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic sclerosis with pulmonary fibrosis and oat cell carcinoma.
    Haqqani MT; Holti G
    Acta Derm Venereol; 1973; 53(5):369-74. PubMed ID: 4127471
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignant scleroderma].
    Pavelka K; Stáva Z; Pazderka V; Dostál C
    Fysiatr Revmatol Vestn; 1971 Apr; 49(2):81-8. PubMed ID: 5103333
    [No Abstract]   [Full Text] [Related]  

  • 16. [The electrocardiogram in chronic obstructive pulmonary emphysema and in primary diffuse pulmonary fibrosis].
    Pivirotto F
    Minerva Med; 1967 Dec; 58(100):4606-12. PubMed ID: 6081725
    [No Abstract]   [Full Text] [Related]  

  • 17. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease.
    Várai G; Earle L; Jimenez SA; Steiner RM; Varga J
    J Rheumatol; 1998 Jul; 25(7):1325-9. PubMed ID: 9676764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Several hemodynamic indices in the early stages of respiratory insufficiency according to polycardiographic and electrocardiographic data].
    Brodskaia AM
    Ter Arkh; 1969; 41(10):54-7. PubMed ID: 5359347
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.